Major side effects occur after coronary syndrome

Published Date: 13 Mar 2023

OSA itself predicted the incidence of MACCE in non-obese patients.

Read Full News

Latest News

Pharmacist-Led Drug Management for HFrEF Cost Effective

New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart failure with reduced ejection fraction.

New Wearable Ultrasound Pacemaker Works Outside the Body

A noninvasive ultrasound device restored heart rhythm in animal models and engineered human heart cells, paving the way for pacemakers without implantation.

Dental Preset for CTA Best Minimises Knee Implant Artefacts

A dental reconstruction setting provides the strongest reduction in metal artefacts during photon-counting CT angiography of the lower leg among patients with total knee replacements.

Warnings Strengthened on Alopecia Areata Medicine Litfulo

The drug should be used in certain patients only if suitable treatment alternatives are not available.

Do Weight-Loss Drugs Improve Heart Health, Quality of Life?

A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.

Muscle-Fat Index Predicts Risks for Heart Failure, Mortality

An imaging-derived muscle-fat index predicts heart failure, cardiovascular deaths, and all-cause deaths more accurately than BMI and waist-based measures.

Todays Updates

Buprenorphine XR Injections Cut 'Need-Based' Opioid Craving

Extended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Todays Updates

Buprenorphine XR Injections Cut 'Need-Based' Opioid Craving

Extended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Latest News

New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart failure with reduced ejection fraction.

A noninvasive ultrasound device restored heart rhythm in animal models and engineered human heart cells, paving the way for pacemakers without implantation.

A dental reconstruction setting provides the strongest reduction in metal artefacts during photon-counting CT angiography of the lower leg among patients with total knee replacements.

The drug should be used in certain patients only if suitable treatment alternatives are not available.

A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.

An imaging-derived muscle-fat index predicts heart failure, cardiovascular deaths, and all-cause deaths more accurately than BMI and waist-based measures.

News All Time

Case Report: Cannabis and Compulsive Showering

An unexpected effect of chronic marijuana use

When Endurance Training Can Be Deadly for Older Athletes

This case shows the danger of one asymptomatic condition in particular

Cardiologist Runs for Mayor; PCSK9 Inhibitor Price Drops; Pregnancy OK After AVR?

Recent developments of interest in cardiovascular medicine

ASPECTS Fails to Reflect Ceiling for Endovascular Stroke Therapy Benefit

Quantitative volumetry better avoids futile reperfusion, per a nationwide study

Chronic Kidney Disease Increasingly Driven By Diabetes

Despite treatment advances, kidney disease burden remained unchanged over the past decade

Giant Cell Arteritis: Are Steroids Overused?

Chronic dosing at levels high enough to cause adverse effects remains common, French data show

A Better Idea of When Mild HCM Is Likely to Go Downhill Fast

— Natural history study probes predictors of worsening in mild disease

Lower Right Heart Reserve Linked to Worse Shunt Outcomes

In patients with heart failure, a lower TAPSE/PASP ratio is linked to higher rates of cardiovascular death or heart failure hospitalisation after interatrial shunting.

Dapagliflozin Cuts Heart Risk in T2D With Advanced Fibrosis

Dapagliflozin can reduce the risk for major adverse cardiovascular events in patients with T2D at a high risk for advanced liver fibrosis, according to a retrospective study.

CMS Proposes TAVR Coverage Framework

Treating patients with symptomatic aortic stenosis does not require collecting further evidence.

Stopping Aspirin Early May Cut Bleeding Risk After Stents

Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.

Obesity Drives 1 in 7 Polypharmacy Cases in Older US Adults

A US cohort study finds that BMI-defined obesity accounts for approximately 15% of polypharmacy cases among older adults, representing an estimated 3.3 million cases.

Why Men Account for Most Drowning Deaths

Drowning deaths are much more common among men, with overconfidence, alcohol, and open-water exposure emerging as key risk factors.

From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management

From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management

Recognizing Recurrent MI Risk: Identifying High-Risk Patients and Clinical Consequences

Recognizing Recurrent MI Risk: Identifying High-Risk Patients and Clinical Consequences

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Recommended News For You

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

Early PET May Help Tailor Therapy in Hodgkin Lymphoma

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

A promising medication could slow brain tumors in children.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Recommended Articles For You

The Impact of Microadenoma on Hormonal Health 

Finding Support: Connecting with the Vitiligo Community 

Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options  

Radiation in Oncology: Advances, Applications, and Accessibility 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Second opinions don't significantly delay breast cancer treatment

2.

Time to Rethink Maintenance Pemetrexed in NSCLC?

3.

Do Anatomy Atlases Reflect Social Inequalities?

4.

Spouses of Cancer Patients May Be at Increased Risk of Suicide

5.

Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma

1.

Lactic Acid-Linked lncRNAs in Wilms Tumor: Decoding the Tumor Microenvironment & Prognosis

2.

Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact

3.

Lymphomatoid Papulosis: What You Need to Know

4.

Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology

5.

Tumor Bed Regeneration and Tissue Reconstruction: Scientific Review and Clinical Insights

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity

2.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

3.

Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

5.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot